Senator calls for AI product review

Sen. Richard Blumenthal says new AI products should face objective review before release, but regulation must be targeted to avoid hurting U.S. competitiveness.

“We're on the verge of losing control completely”

Tech leaders sound alarm on AI risks

Anthropic CEO Dario Amodei and OpenAI's Sam Altman have warned about major risks from rapidly advancing AI models and called for slowing development.

Trump dismisses AI safety concerns

President Trump has called AI safety fears a hoax and scam, arguing that beating China in AI dominance is the priority for his administration.

China regulates AI as regime threat

Blumenthal notes that China is regulating AI because it could threaten their government, showing that even authoritarian nations see the need for oversight.

FDA model offers regulatory blueprint

Blumenthal compares AI oversight to pharmaceutical regulation, saying Congress should delegate responsibility to experts rather than trying to regulate AI directly.

“I think we need to delegate some of this responsibility to the experts”

Social media shows cost of delay

Blumenthal warns that waiting to regulate AI mirrors the social media mistake, where algorithms now drive toxic content to children and regulators are still catching up.

“The horse is out of the barn, algorithms are driving toxic content at kids”